Your browser is no longer supported. Please, upgrade your browser.
AZN AstraZeneca PLC daily Stock Chart
AstraZeneca PLC
Index- P/E45.65 EPS (ttm)0.85 Insider Own0.50% Shs Outstand2.59B Perf Week-2.61%
Market Cap100.67B Forward P/E18.51 EPS next Y2.10 Insider Trans0.00% Shs Float2.59B Perf Month-9.81%
Income2.16B PEG2.14 EPS next Q0.38 Inst Own19.30% Short Float0.64% Perf Quarter6.92%
Sales22.09B P/S4.56 EPS this Y-9.60% Inst Trans0.11% Short Ratio3.07 Perf Half Y-0.72%
Book/sh4.92 P/B7.89 EPS next Y22.43% ROA3.50% Target Price45.77 Perf Year7.84%
Cash/sh2.19 P/C17.72 EPS next 5Y21.30% ROE17.30% 52W Range34.38 - 43.29 Perf YTD2.16%
Dividend1.40 P/FCF- EPS past 5Y-3.60% ROI10.90% 52W High-10.38% Beta0.51
Dividend %3.61% Quick Ratio0.80 Sales past 5Y-3.10% Gross Margin79.60% 52W Low12.86% ATR0.62
Employees64400 Current Ratio1.00 Sales Q/Q11.10% Oper. Margin15.30% RSI (14)32.28 Volatility1.44% 1.26%
OptionableYes Debt/Eq1.53 EPS Q/Q-22.10% Profit Margin9.80% Rel Volume1.00 Prev Close38.77
ShortableYes LT Debt/Eq1.39 EarningsApr 26 BMO Payout163.20% Avg Volume5.41M Price38.80
Recom1.60 SMA20-5.55% SMA50-5.11% SMA200-0.14% Volume5,425,399 Change0.08%
Apr-02-19Downgrade UBS Neutral → Sell
Feb-05-19Initiated Exane BNP Paribas Outperform
Jan-25-19Upgrade Shore Capital Hold → Buy
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Aug-16-18Downgrade Jefferies Buy → Hold
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
May-12-17Upgrade Credit Suisse Underperform → Neutral
Apr-10-17Downgrade Jefferies Buy → Hold
Apr-18-19 09:38AM  AVEO Pharmaceuticals Down More Than 40% in 90 Days: Here's Why Zacks
Apr-17-19 11:06AM  Top Ranked Income Stocks to Buy for April 17th Zacks
Apr-15-19 09:57AM  Clovis Stalls Mid-Stage Rubraca Study for Bladder Cancer Zacks
05:28AM  London's FTSE 100 tugged down by miners; IWG lifts midcaps Reuters
Apr-12-19 10:30AM  Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal Zacks
09:55AM  Dow 30 Stock Roundup: Procter & Gamble Hikes Dividend, Boeing Q1 Commercial Deliveries Fall Zacks
Apr-10-19 03:24PM  Here's what to expect from the stock market next month Investopedia
11:11AM  Is AstraZeneca Stock Worth Buying Before Earnings? InvestorPlace
10:46AM  Alkermes Reports Positive Data From Schizophrenia Study Zacks
10:20AM  J&J (JNJ) to Kick-start Pharma Q1 Earnings: What's in Store? Zacks
10:14AM  AstraZeneca/Merck's Lynparza Wins EU Nod for Breast Cancer Zacks
Apr-09-19 11:24AM  PhaseBio Stock Up on Breakthrough Therapy Status for PB2452 Zacks
10:30AM  Inovio Earns 3rd Milestone Fee From AstraZeneca for MEDI0457 Zacks
Apr-08-19 09:41AM  The Zacks Analyst Blog Highlights: Pfizer, Teva, Novartis, Merck and AstraZeneca Zacks
03:04AM  Is AstraZeneca PLC's (LON:AZN) Balance Sheet A Threat To Its Future? Simply Wall St.
Apr-07-19 10:33PM  City of London alarmed at EUs no-deal Brexit equity trading plan Financial Times
Apr-06-19 03:41AM  Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men Zacks
Apr-05-19 09:26PM  Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men Zacks
10:34AM  Will Ironwood Suffer From Dependence on Linzess' Progress? Zacks
10:20AM  Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU Zacks
09:33AM  Myriad Genetics Expands CDx Tie Up With AstraZeneca & Merck Zacks
01:15AM  Investors Chronicle: Hostelworld. YouGov, AstraZeneca Financial Times
Apr-04-19 10:36AM  Inovio's HPV Candidate Shows Efficacy in Pilot Study, Stock Up Zacks
Apr-03-19 10:22AM  Clovis Posts Data on Rubraca Study for Pancreatic Cancer Zacks
07:23AM  Daiichi Sankyo Company, Limited -- Moody's: Daiichi Sankyo's collaboration with AstraZeneca is positive for the former's oncology franchise Moody's
Apr-02-19 11:15AM  AstraZeneca May Not Have the Cash Flow to Pull Off Its Big Expansion
10:04AM  Merck's Keytruda Gets Nod for First-Line Lung Cancer in China Zacks
09:44AM  Advaxis Up on Positive Early-Stage Immunotherapy Study Data Zacks
06:53AM  Stocks to watch: Rolls-Royce, Lyft, AstraZeneca, Fevertree, Pandora Financial Times
06:32AM  Zeneca Wilmington Inc. -- Moody's changes outlook on AstraZeneca's A3 ratings to stable; affirms ratings Moody's
Apr-01-19 03:36PM  AstraZeneca's Selumetinib Gets Breakthrough Therapy Status Zacks
12:12PM  The Dow Is Gaining Because Good News From China Is Good News for Stocks
11:19AM  AstraZeneca's Rare Pediatric Genetic Disorder Drug Granted Breakthrough Therapy Designation Benzinga
06:30AM  Selumetinib Granted US Breakthrough Therapy Designation in Neurofibromatosis Type 1 Business Wire
Mar-29-19 04:47PM  AVEO Pharmaceuticals (AVEO) to File NDA for Fotivda with FDA Zacks -5.93%
04:33PM  Why AstraZeneca, Yeti Holdings, and CannTrust Holdings Slumped Today Motley Fool
01:41PM  FTSE 100 gains as trade progress offsets latest Brexit setback Reuters
12:48PM  AstraZeneca (AZN) Signs $6.9B Cancer Deal with Daiichi Sankyo Zacks
11:30AM  Japan's Daiichi Strikes Cancer Therapy Deal With AstraZeneca Worth Up To $6.9B Benzinga
10:42AM  Mondelez may be shopping, AstraZeneca makes major deal, Tim Cook may testify Yahoo Finance
10:34AM  AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal Reuters
10:19AM  Mondelez may be shopping, AstraZeneca makes major deal, Tim Cook may testify Yahoo Finance Video
09:28AM  AstraZeneca in cancer deal with Daiichi Sankyo Associated Press
09:10AM  AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal Reuters
09:06AM  RH Stock Tumbles, AstraZeneca Slides and 3 More Friday Morning Movers
08:42AM  AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal Reuters
08:16AM  AstraZeneca Slides on $6.9 Billion Cancer Drug Deal with Japan's Daiichi Sankyo
08:10AM  Stocks to watch: AstraZeneca, Tui, H&M, Auto Trader, Jupiter, Evraz Financial Times
08:06AM  Is This a Drug Deal or a Rights Offering? Bloomberg
06:43AM  AstraZeneca Bets $6.9 Billion in Japan Cancer Therapy Deal Bloomberg
03:51AM  Nikkei up on U.S.-China trade talk optimism; Daiichi Sankyo jumps Reuters
12:46AM  AstraZeneca in $6.9bn cancer deal with Daiichi Sankyo Financial Times
Mar-28-19 08:08PM  AstraZeneca and Daiichi Sankyo to jointly develop cancer drug Reuters
01:29PM  European shares give up gains as banks weigh amid concerns on growth, Brexit Reuters
10:43AM  AstraZeneca's Forxiga Gets Nod in Japan for Type I Diabetes Zacks
04:44AM  There's a feeling of 'deep uncertainty': AstraZeneca CNBC Videos
Mar-27-19 05:39PM  Calithera (CALA) Initiates Phase I/II Study of Telaglenastat Zacks
05:09PM  Aldeyra's Eye Drug Meets Main Goal in Study, Shares Surge Zacks
Mar-26-19 08:15PM  Were Hedge Funds Right About AstraZeneca plc (AZN)? Insider Monkey
03:48PM  Bayer & JNJ Settle Numerous Xarelto Lawsuits for $775 Million Zacks
Mar-25-19 10:10AM  AstraZeneca's Forxiga Gets EC Approval for Type-I Diabetes Zacks
03:58AM  EU approves AstraZeneca's drug for adjunct use in Type-1 diabetes Reuters
03:54AM  EU approves AstraZeneca's drug for adjunct use in Type-1 diabetes Reuters
Mar-21-19 06:31PM  J&J to record $700 million charge related to abandoned drug program Reuters
06:18PM  J&J to record $700 mln charge related to abandoned drug program Reuters
10:10AM  Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market Zacks
08:11AM  The Zacks Analyst Blog Highlights: Las Vegas Sands, Phillips 66, AstraZeneca, Hilton and AutoZone Zacks
Mar-20-19 03:21PM  Top Stock Reports for Las Vegas Sands, Phillips 66 & AstraZeneca Zacks
Mar-19-19 12:00PM  The Zacks Analyst Blog Highlights: Merck, Adobe, Broadcom, AstraZeneca and Ross Stores Zacks
11:57AM  PhaseBio Stock Up on Positive Data From PB2452 Phase I Study Zacks
11:56AM  Roche's Tecentriq Gets FDA Approval for Difficult Lung Cancer Zacks
10:21AM  Why You Should Buy ABBV Stock for Income and Value InvestorPlace
08:40AM  Large-Cap Pharmaceuticals Industry Outlook: A Recovery Ahead? Zacks
07:40AM  The Daily Biotech Pulse: FDA Nod For Roche And Amphastar, Milestone Payment Kicks In For Affimed Benzinga
Mar-18-19 03:53PM  Novartis' (NVS) Alcon Acquired PowerVision for $285 Million Zacks
01:15PM  Top Research Reports for Merck, Adobe & Broadcom Zacks
11:28AM  Inovio's Early/Mid-Stage Vaccine Pipeline Exhibits Growth Zacks
09:01AM  First Sub-Analyses from the DECLARE-TIMI 58 Trial Further Support the Cardiovascular Effects of FARXIGA in Type 2 Diabetes Business Wire
08:06AM  AstraZeneca Up This Year on New Drugs & Pipeline Progress Zacks
Mar-17-19 08:50AM  3 Dividend Stocks That Should Pay You the Rest of Your Life Motley Fool
Mar-16-19 12:00PM  3 Top Diabetes Stocks to Watch in March Motley Fool
08:35AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings Benzinga
Mar-15-19 11:07PM  Guardant Health (GH) Q4 2018 Earnings Conference Call Transcript Motley Fool
11:38AM  AVEO Pharmaceuticals (AVEO) Q4 Earnings Beat, Revenues Lag Zacks
11:28AM  Merck's Keytruda Gets EU Approval for Difficult Lung Cancer Zacks
Mar-14-19 10:00AM  Here's Why Momentum Investors Will Love Astrazeneca (AZN) Zacks
09:23AM  Is Britain Headed for a Soft Brexit? 5 Picks Zacks
Mar-13-19 10:03AM  Inovio (INO) Misses on Q4 Earnings & Revenues, Shares Down Zacks
Mar-12-19 04:29PM  BioNTech hires banks for IPO worth up to $800 million - sources Reuters
03:22PM  5 Active Mutual Funds Worth Their Expenses InvestorPlace
07:31AM  How the UK Makes Money Investopedia
Mar-11-19 01:41PM  Here's Why Seres Therapeutics Stock Soared Today Motley Fool
12:58PM  Seres teams up with AstraZeneca to explore microbiome benefits in cancer treatment American City Business Journals
12:26PM  Bayer Submits Application in EU for Prostate Cancer Drug Zacks
10:07AM  Sanofi's Dupixent Gets FDA Priority Status for Nasal Polyps Zacks
10:06AM  The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's Zacks
09:30AM  Should Value Investors Pick AstraZeneca PLC (AZN) Stock? Zacks
08:00AM  AstraZeneca to Present New Cardiovascular Data on FARXIGA in Type 2 Diabetes At ACC 2019 Business Wire
Mar-08-19 01:45PM  Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs Zacks
Mar-07-19 07:00AM  Recent Analysis Shows Veeva, Mobile TeleSystems OJSC, Jacobs Engineering Group, Perrigo Company plc, AstraZeneca, and Primoris Services Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASTRAZENECA PLC10% OwnerOct 22Buy5.00600,0003,000,0003,004,554Oct 24 04:16 PM
ASTRAZENECA PLC10% OwnerSep 28Buy15.00246,6663,699,9902,164,855Oct 02 09:35 PM